Walgreens Says Insulin Pen Settlement Suit Has No 'Heat'
By Jeff Montgomery · November 20, 2023, 7:51 PM EST
An attorney for pharmacy giant Walgreens' parent company told a Delaware vice chancellor on Monday that a stockholder derivative complaint seeking more than $200 million from directors who allegedly ignored intentional...
To view the full article, register now.